Market Place
Sourcing Support
Theravance Biopharma Misses Phase 3 CYPRESS Goal, Cuts Costs
03 Mar 2026 //
PR NEWSWIRE
Theravance Bio To Host Virtual Investor Event On Ampreloxetine
20 Nov 2025 //
PR NEWSWIRE
Theravance Bio to Share Ampreloxetine Data at Symposium
29 Oct 2025 //
PR NEWSWIRE
Theravance Bio Completes Enrollment in Pivotal Ph 3 CYPRESS Study
25 Aug 2025 //
PR NEWSWIRE
Theravance Biopharma to Present Ampreloxetine at MSA Congress
09 May 2025 //
PR NEWSWIRE
Theravance to Present Ampreloxetine Analysis at 2025 MSA Congress
28 Apr 2025 //
PR NEWSWIRE
Theravance Biopharma Hosts Virtual KOL Event on Ampreloxetine
10 Apr 2024 //
PR NEWSWIRE
Theravance Biopharma to Present New Ampreloxetine Data
16 Nov 2023 //
PR NEWSWIRE
Theravance Biopharma to Present New Ampreloxetine Data at the 2023
28 Aug 2023 //
PR NEWSWIRE
Ampreloxetine Data in Neurogenic Orthostatic Hypotension to be Presented
02 Nov 2022 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.